Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length

Olga G Ovchinnikova1, Logan P Treat2, Tanisha Teelucksingh1

  • 1Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Mbio
|May 4, 2023
PubMed

Insights

Klebsiella pneumoniae virulence is linked to its capsule. The RmpD protein regulates capsule chain length, impacting hypermucoviscosity and increasing infection severity.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Klebsiella pneumoniae causes severe nosocomial infections.
  • Antibiotic resistance limits treatment options.
  • Hypervirulent K. pneumoniae (hvKp) exhibits hypermucoviscosity (HMV), increasing virulence.

Purpose of the Study:

  • To elucidate the role of RmpD in hvKp hypermucoviscosity.
  • To determine the structural impact of RmpD on capsular polysaccharide (CPS).
  • To investigate the interaction between RmpD and capsule biosynthesis machinery.

Main Methods:

  • Structural analysis of CPS from K. pneumoniae with and without RmpD.
  • Reconstitution of RmpD-mediated CPS modification in E. coli.
  • Biochemical assays to detect RmpD-Wzc interaction.

Main Results:

  • RmpD expression results in more uniform CPS chain length.
  • RmpD binds to Wzc, a key capsule export protein.
  • RmpD confers HMV and regulates CPS chain length in E. coli.

Conclusions:

  • RmpD regulates CPS chain length via interaction with Wzc, contributing to HMV in K. pneumoniae.
  • The RmpD-Wzc mechanism may be conserved across pathogens expressing similar capsule machinery.